Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions: Postmenopausal Osteoporosis; Postmenopause; Hyperparathyroidism, Secondary; Hypovitaminosis D; Hyperparathyroidism, Primary Intervention: Drug: Cholecalciferol Sponsors: Hospital Regional 1o de Octubre; Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hyperparathyroidism | Mexico Health | Orthopaedics | Osteoporosis | Research | Vitamin D3